Clincosm LogoSign in Get a demo

Prevalence and Sequelae of Computer Vision Syndrome in Egyptian Universities

Sponsor
Sohag University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05187221
Collaborator
(none)
10,000
Enrollment
2
Locations
2.9
Anticipated Duration (Months)
5000
Patients Per Site
1710
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

CVS-F4 questionnaire will be used as an instrument to survey CVS prevalence and severity among medical students

Condition or Disease Intervention/Treatment Phase
  • Behavioral: CVS Group

Detailed Description

CVS-F4 (30 questions) will be an online survey via the SurveyMonkey Company. We will collect the responses and analyze the results. Informed consent will be obtained from the participants as an item within the survey itself that he/she agrees to use his/her data in this research work. The questionnaire includes questions regarding potential ocular, extra-ocular, musclo-skeletal and neuro-psychatric complains caused by CVS. Complete statistical analysis of the survey data will be done using univariate and multivariate logistic and linear regression analysis.

Study Design

Study Type:
Observational
Anticipated Enrollment :
10000 participants
Observational Model:
Case-Control
Time Perspective:
Cross-Sectional
Official Title:
Evaluation of the Fourth Form (CVS-F4) Survey Efficacy in Detection of the Prevalence and Sequelae of Computer Vision Syndrome in Egyptian Universities
Anticipated Study Start Date :
Feb 1, 2022
Anticipated Primary Completion Date :
Mar 1, 2022
Anticipated Study Completion Date :
May 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Control Group

The participants will respond to CVS-F4 questionnaire online via SurveyMonkey to report their potential CVS complains and associated screen factors as screen-time, screen-size, screen-resolution and other factors. This group will contains participants with no CVS complains.

Behavioral: CVS Group
CVS-F4 will be an online survey via the SurveyMonkey Company. The participants will report their potential CVS complains and associated screen factors as screen-time, screen-size, screen-resolution and other factors. We will collect the responses and analyse the results. Informed consent will be obtained from the participants as an item within the survey itself that he/she agrees to use his/her data in this research work. This group will contain participants with CVS complains.

Outcome Measures

Primary Outcome Measures

  1. Number of participants suffering from CVS [3 months]

    will be reported in form of percentage (%) of students with CVS

  2. Rate of CVS symptoms-attacks [3 months]

    The results will be presented as annual percentage

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

  • university students

  • university staff members

Exclusion Criteria:

  • ocular surgery

  • amblyopia

  • anisometropia

  • strabismus

  • systemic disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Faculty of medicine Sohag, Sohag Egypt 82425
2 Faculty of medicine Sohag Egypt 82425

Sponsors and Collaborators

  • Sohag University

Investigators

  • Principal Investigator: Mohammed Iqbal, MD, PhD, Professor of Ophthalmology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Prof. Mohammed Iqbal, Professor of Ophthalmology, Sohag University
ClinicalTrials.gov Identifier:
NCT05187221
Other Study ID Numbers:
  • Soh-Med-21-12-31
First Posted:
Jan 11, 2022
Last Update Posted:
Jan 27, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:
Syndrome

Study Results

No Results Posted as of Jan 27, 2022